Matthew Maxwell Donley Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity
Matthew Maxwell Donley is Chief Operating Officer of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 680,465 shares of AUPH, which is worth approximately $5.26 Million. The most recent transaction as insider was on Mar 04, 2025, when has been sold 58,991 shares (Common Stock) at a price of $7.92 per share, resulting in proceeds of $467,208. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
680K
16.5%
3M change
16.5%
12M change
Total Value Held
$5.26 Million
Matthew Maxwell Donley Transaction History
MMD
Matthew Maxwell Donley
Chief Operating Officer
Victoria, A1